中文版
English
 
Search:  
 
Chinese herb extracts
functional heath food
new Chinese medicines
the management of hospital
USA FDA
Europe plant drugs admit


LPHT capsule
Lung Peace and Heart Tranquility (shorted for “LPHT” hereinafter) capsule
Item Title:
    Anti chronic bronchitis, emphysema and Lung heart disease capsule
Item Contents:
    The chronic bronchitis and emphysema are the chief disease and reason of COPD; the two chief diseases through chronic bronchitis and emphysema cause the lung heart disease. The 90% lung heart disease is infected by chronic bronchitis, the death rate of lung heart disease is on the top of the other illnesses especially in a rural area, its death reason is in the third of the other illnesses in the city area, followed by cerebrovascular disease and tumour. This disease threatened the patients’ health and people’s living conditions. The LPHT capsule is made from the traditional Chinese old experiential prescription and technical science method. It is good to tracheitis, reliving hyperkinesias, peacing asthma, restraining cough, lustrating sputum, annihilating viruses and aggrandizing the human heart. The LPHT capsule can enhance the patients’ resistant ability, control and relieve the sufferings of chronic bronchitis, emphysema and Lung heart disease. The LPHT capsule can ameliorate the COPD and the patients’ living quality, it is kind of prepared new drugs.
Market Prospect:
    COPD and lung heart disease are the serious illness in the world. The patients who got chronic block lung disease occupied 4%, and 13% was occupied by age of fifty, higher than the young. At present the current medicine on the market is effect to staunch cough, peace asthma, modulate breath and desalt sputum but for the inducing right ventricle enhancing of pulmonary artery high pressure is not useful, taking no effect. So, the LPHT capsule is more imported for the needed patients. After 10 years more clinical treatments, we get the results, for example, among the 135 patients, 83% charmed away in chronic bronchitis disease, among the 68 patients, 69% got well in emphysema disease, among 52 patients, we get 80% well in lung heart disease. Comparing with some medicine, it shows better than others. The LPHT capsule has more competitive advantage, it’s made from nature herb materials, it’s of a quite market competition and market occupations.
Gross Investment and Capital Source:
    This item need 290,000 RMB in gross investment, the fund comes from by co-operation or jointed venture.
Anticipating Economy and Social Profit:
    After completing the item, mock unit workout, for example if we have 25,000 patients who need 8 bottles per month (60 pills on bottle), taken by 4 months each year, so we get the gross profit totally 6400,000 RMB Yuan for 800,000 bottles, each bottle will get 8 RMB Yuan profit.
Cooperative Style:
    Co-developed style, joint-venture



BCAS capsule
Block Coronary Artery Sharp KMLT (shorted for “BCAS” hereinafter) capsule
Item Title:
    Anti-coronary heart disease: BCAS capsule
Item Contents:
    The item is both a key technical one in Shannxi province and a new drug research one in States Chinese Medicine Administration. At present, the drugs to cure coronary heart disease sell so many in the city, but the drug effect is not as good as people expect, the function of the drug is not good, for precaution of anti-coronary heart disease effect is less than it products. Due to this point, the item is developed by the illness system of anti anoxemic heart disease, which depicts “fat piles in the blood, the dregs of retarding heart cycle” function. The new drugs for anti coronary heart disease is not only cure the outer idea but also can cure the inner basical reason. The BCAS capsule is made from ginseng, sand whin, earthworm, and cilantro, ect. almost 10 kind of Chinese medicine. This capsule can defend coronary disease and reduce the fat in the blood. The clinical treatment verified that the capsule can resolve blood cilantro and eliminate the thrombus, curative effect is stable, safe, innoxious.
Market Prospect:
    The coronary heart disease is a kind of world-widely diseases among the people. According to the epidemiology investigation and corpse inspect statistical evaluation, among the age of 40 or older people, at least there is over 30 percent people has been infected by this of disease. American people died of the coronary heart disease about 50,000 per year, Chinese people about 26,000~39,000 (above 70 percent people died due to the late treatment) in China. BCAS capsule can prevent and kill the coronary heart disease, its medical effect is obvious for very patient, it’s good for long-term taken, we have clinical treatment for about 520 patients, through five years observations, the accident rate is only 0.19%, anther 266 patients, total validity reaches to 89.8%. The materials of this capsule can get easily; making method is scientific, safe. The price of the capsule is cheap and low. This capsule is a green drugs, it rewarded the gold medal in the year of 1995 China New Techniques Product Fairs.
Gross Investment and Capital Source:
    This item need 380,000 RMB in gross investment, the fund comes from by co-operation or jointed venture.
Anticipating Economy and Social Profit:
    After completing the item, mock unit workout, for example if we have 10,000 patients who need 6 bottles per month (60 pills one bottle), taken by 4 months in spring and winter each year, so we get the gross profit totally 1920,000 RMB Yuan for 240,000 bottles, each bottle will cost 8 RMB Yuan; if we provide for 50,000 patients, we will get 9600,000 RMB Yuan in gross profit.
Cooperative Style:
    Co-developed style, joint-venture
 

 
| longann group | news | products & services | sales | research & development | feedback | jobs | contact us
© 2004 Longann.com. All rights reserved. Designed by ArtHtml.com.